7+ pre market on news , then pulled back in 4. range for a few days now look 14+
I don't know if I am that lucky :). Never been in a stock with such great move.
ACAD's treatment worked BETTER than expected in the trial. No comparison to CLSN.
but acad failed its first phase 3 trial